Emerging epidemic of hepatitis C virus infections among young nonurban persons who inject drugs in the United States, 2006-2012.
about
Role of Serologic and Molecular Diagnostic Assays in Identification and Management of Hepatitis C Virus InfectionThe changing landscape of hepatitis C virus therapy: focus on interferon-free treatmentHepatitis C virus: why do we need a vaccine to prevent a curable persistent infection?Elevation of Alanine Aminotransferase Activity Occurs after Activation of the Cell-Death Signaling Initiated by Pattern-Recognition Receptors but before Activation of Cytolytic Effectors in NK or CD8+ T Cells in the Liver During Acute HCV InfectionSofosbuvir/velpatasvir regimen promises an effective pan-genotypic hepatitis C virus cure.Global epidemiology and burden of HCV infection and HCV-related disease.The structural and health policy environment for delivering integrated HIV and substance use disorder treatments in Puerto Rico.Identifying and characterizing hepatitis C virus hotspots in Massachusetts: a spatial epidemiological approach.Broadly neutralizing antibodies with few somatic mutations and hepatitis C virus clearanceEstimation of State-Level Prevalence of Hepatitis C Virus Infection, US States and District of Columbia, 2010Needle exchange programs for the prevention of hepatitis C virus infection in people who inject drugs: a systematic review with meta-analysis.Access to healthcare insurance and healthcare services among syringe exchange program clients in Massachusetts: qualitative findings from health navigators with the iDU ("I do") Care Collaborative.Risk factors for hepatitis C seropositivity among young people who inject drugs in New York City: Implications for preventionHurdles to the Development of Effective HBV Immunotherapies and HCV VaccinesToward a more accurate estimate of the prevalence of hepatitis C in the United States.Comparison of Rapid Point-of-Care Tests for Detection of Antibodies to Hepatitis C Virus.Lessons from Nature: Understanding Immunity to HCV to Guide Vaccine Design.Opioid Use Trajectories, Injection Drug Use, and Hepatitis C Virus Risk Among Young Adult Immigrants from the Former Soviet Union Living in New York City.Single-Genome Sequencing of Hepatitis C Virus in Donor-Recipient Pairs Distinguishes Modes and Models of Virus Transmission and Early Diversification.Underascertainment of acute hepatitis C virus infections in the U.S. surveillance system: a case series and chart review.New prospects for the treatment and prevention of hepatitis C in children.Short term health-related quality of life improvement during opioid agonist treatmentInterferon Lambda 4 Genotype Is Associated With Jaundice and Elevated Aminotransferase Levels During Acute Hepatitis C Virus Infection: Findings From the InC3 Collaborative.Screening and evaluation of hepatitis C virus infection in pregnant women on opioid maintenance therapy: A retrospective cohort study.Hepatitis C Virus Testing and Linkage to Care in North Carolina and South Carolina Jails, 2012-2014Prevention of Hepatitis C by Screening and Treatment in U.S. Prisons.Linkage to Care for Suburban Heroin Users with Hepatitis C Virus Infection, New Jersey, USA.Performance of Risk-Based and Birth-Cohort Strategies for Identifying Hepatitis C Virus Infection Among People Entering Prison, Wisconsin, 2014.Harm reduction for young people who use prescription opioids extra-medically: Obstacles and opportunities.Emergency Department Screening for Hepatitis C Virus: Geographic Reach and Spatial Clustering in Central Alabama.Increasing Infectious Endocarditis Admissions Among Young People Who Inject Drugs.Preclinical evaluation of multi antigenic HCV DNA vaccine for the prevention of Hepatitis C virus infection.Review article: treatment as prevention - targeting people who inject drugs as a pathway towards hepatitis C eradication.Utilization of buprenorphine and methadone among opioid users who inject drugs.Hepatitis C: Review of the Epidemiology, Clinical Care, and Continued Challenges in the Direct Acting Antiviral Era.Scaling up HCV prevention and treatment interventions in rural USA - model projections for tackling an increasing epidemic.Health outcomes associated with illicit prescription opioid injection: A systematic review.Buprenorphine implants in medical treatment of opioid addiction.The American Society of Transplantation Consensus Conference on the Use of Hepatitis C Viremic Donors in Solid Organ Transplantation.Hepatitis C Virus Infection Among Women Giving Birth - Tennessee and United States, 2009-2014.
P2860
Q26776408-E618B8B8-1D23-4633-A164-C672C197F692Q26795559-EB1F274F-8405-44CE-BC69-2E736C4FA8A9Q26799141-3069515E-FBD4-4482-A3B9-82D32391CB9AQ28553005-5AE2727C-2662-4084-BB17-197359CE9616Q30235430-59433983-32A7-4574-BEF6-CF8F64703553Q30240220-AE5DA052-6473-4663-877D-99EE1AD193CEQ30842836-6C180820-1888-4156-8828-F7709E150168Q33587555-EEB64C43-0DAB-4D00-8E9E-31F8129328D5Q33631104-9C274415-55EC-4739-A30B-FAEF23710B22Q33696050-F428FB96-BD88-4DBF-8CD7-B4E71152F5B7Q33702754-C4F0E9E2-B18E-4FD1-93A2-B09DCB47AF5EQ33706376-3EA6410F-8607-4A13-808F-407763A44B9FQ33707925-98BEE3E6-6070-45AF-9E32-082B7DE7C395Q33840260-26CB5AAA-9170-471D-B1FB-10B8FAF6AC47Q34484872-CFC328D7-8FF4-4252-A0C9-30FF5C47D2D8Q35935659-F2FF9BFB-6CE7-4B8C-9CBF-8252E5F9FD68Q36064836-E918B664-EE10-425E-B6A8-D1292498ABC3Q36093144-9BA0B8E9-781E-4D92-A329-C3DD5D95E46AQ36433960-F68B468A-40FB-4945-965C-A56850F2792EQ36514676-CB5B4D6A-5F72-49AC-A049-59D8BA8B674DQ36608054-7E3A9BCE-6A20-4C9F-AC37-B186430045CBQ36652120-158EB4A7-CA73-4400-B82C-DB7C5024F656Q36670894-64FDB5C0-D199-4896-8CC6-2ED4CF2E5E16Q36785500-4695CDC1-023D-4A88-9583-10EE079FC8D0Q36858898-970BEB87-8196-437A-97B5-B1D77BE1DAFFQ36862066-9E00245D-3BBE-4093-88B8-9DF36B798444Q36884996-FA63735C-C704-4B48-9A5E-14834C3B5030Q37075712-A1DE95C9-2141-4206-BCE2-3F1620C15B20Q37154709-9769064F-CF54-421A-AA3C-AB361B54329EQ37220279-8686CF17-EB3B-47D6-A663-F6A62C3B7E6EQ37375396-9BA7F0AA-A9C0-4474-89B6-E27046623B25Q37684017-23F7820F-A9D0-4477-B2F5-0B48ECDC3D26Q38380343-0E42EE95-D3BF-4CFE-8697-57DBF2B8E63AQ38630550-38577BB6-41CA-4297-B8C5-9503CC4C6A8BQ38635796-90C5A3DC-BBED-442E-8D01-39DB6EB56B1CQ38666907-EA96B17C-9DBB-4BA4-AE09-C87870EBD5DFQ38670195-3E99AD87-FF03-4444-BB06-86C2C5CE7323Q38750450-FBE36BEE-2EAE-400D-A1F5-416E0597EA47Q38757351-08E77E0B-BE4F-4672-BF00-045FC7436CEAQ38792091-AF7352DE-060F-44E8-A036-3CE76EF36768
P2860
Emerging epidemic of hepatitis C virus infections among young nonurban persons who inject drugs in the United States, 2006-2012.
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Emerging epidemic of hepatitis ...... the United States, 2006-2012.
@ast
Emerging epidemic of hepatitis ...... the United States, 2006-2012.
@en
type
label
Emerging epidemic of hepatitis ...... the United States, 2006-2012.
@ast
Emerging epidemic of hepatitis ...... the United States, 2006-2012.
@en
prefLabel
Emerging epidemic of hepatitis ...... the United States, 2006-2012.
@ast
Emerging epidemic of hepatitis ...... the United States, 2006-2012.
@en
P2093
P2860
P356
P1476
Emerging epidemic of hepatitis ...... the United States, 2006-2012.
@en
P2093
Anil G Suryaprasad
Benjamin A Kupronis
Beth-Ann Eichler
Chardé Fisher
Daniel R Church
Janet Hamilton
Jianglan Z White
John W Ward
P2860
P304
P356
10.1093/CID/CIU643
P407
P577
2014-08-11T00:00:00Z